4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-24-111732
CEO sold 60,000 shares at $24.60 ($1,476,024)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2024-09-30 | Sale 10b5-1 | −60,000 | $24.60 | $1,476,024 | 938,659 | D |
| Open-market sales · 60,000 sh · avg $24.60 · $1,476,024 | |||||||
Loading xslF345X05/ownership.xml…